Zafrira Avnur's most recent trade in Eloxx Pharmaceuticals Inc was a trade of 20,000 Stock Options (Right to Buy) done . Disclosure was reported to the exchange on June 15, 2022.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Eloxx Pharmaceuticals Inc | Zafrira Avnur | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 20,000 | 20,000 | - | - | Stock Options (Right to Buy) | |
Eloxx Pharmaceuticals Inc | Zafrira Avnur | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 19 May 2021 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) | |
Eloxx Pharmaceuticals Inc | Zafrira Avnur | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 20 May 2020 | 20,000 | 20,000 | - | - | Stock Option (Right to Buy) |